# GAMIFANT

NDC: 66658-501
Generic name: emapalumab-lzsg
Labeler / Manufacturer: Swedish Orphan Biovitrum AB (publ)
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION
Routes: INTRAVENOUS
Marketing started: 20190517

FDA application: BLA761107

## Active ingredients

- EMAPALUMAB: 10 mg/2mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"66658-501"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=66658-501
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a865e0ef-8685-4f69-8838-648c4f3bab47